Study Links Specific Drugs to Delusions of Parasitosis Risk

Researchers conducted a case-control study of biometric and pharmaceutical data from 34 patients with delusions of parasitosis, which they compared to an age-matched control group of 53 women.

Related Keywords

United States ,America ,Brett Kopelan ,Amryt Pharma ,Web Community ,Krystal Biotech ,Chiesi Global Rare Diseases ,Safety Study ,Epidermolysis Bullosa ,Wound Management ,Wound Care ,Delusions Of Parasitosis ,Delusional Parasitosis ,Kbom Amp 039s Syndrome ,Delusion ,Wound ,Biologic Therapy ,Iologics ,Healthcare And Medical Technology ,Ealth And Medical Tech ,Ealth And Med Tech ,Ealth And Medical Technology ,Healthcare Technology ,Medical Technology ,Biomedical Technology ,Biotechnology ,Biotech ,Clinical Research ,Clinical Trials ,